LABCORP HOLDINGS INC. LH
NYSE · XNYS · stock · Services-Medical Laboratories · website · IPO 1991-04-24
LABCORP HOLDINGS INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 28.8% | 27.9% | 27.7% | 31.3% | 38.0% |
| Operating margin | 9.9% | 8.4% | 6.0% | 12.1% | 23.2% |
| Net margin | 6.3% | 5.7% | 3.4% | 10.8% | 18.1% |
| FCF margin | 8.6% | 8.4% | 7.2% | 12.9% | 20.5% |
| Return on assets | 4.8% | 4.1% | 2.5% | 6.3% | 11.7% |
| Return on equity | 10.2% | 9.3% | 5.3% | 12.7% | 23.1% |
| Debt / equity | 0.59× | 0.66× | 0.51× | 0.50× | 0.53× |
| Current ratio | 1.42 | 1.44 | 1.17 | 1.50 | 1.92 |
| Revenue growth | 7.2% | 7.0% | 2.5% | -9.7% | -6.0% |
Source: SEC EDGAR filings · CIK 0000920148 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.